Dolby Laboratories (DLB) Long-Term Deferred Tax (2009 - 2026)

Dolby Laboratories has reported Long-Term Deferred Tax for 18 years, with the latest figure at $209.3 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 6.31% year-over-year to $209.3 million; the trailing twelve-month figure through Mar 2026 stood at $209.3 million (down 6.31% YoY), and the FY2025 full-year result was $214.4 million, down 2.46% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $209.3 million, down from $214.3 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $228.6 million in Q2 2025, with the low at $175.2 million in Q2 2022.
• Historically, Long-Term Deferred Tax has averaged $207.2 million across 5 years, with a median of $209.3 million in 2026.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax increased 29.28% — and 2026, when it fell 6.31%.
• Dolby Laboratories' Long-Term Deferred Tax stood at $192.2 million in 2022, then advanced by 7.54% to $206.7 million in 2023, then climbed by 9.85% to $227.0 million in 2024, then retreated by 5.58% to $214.3 million in 2025, then decreased by 2.34% to $209.3 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $209.3 million (Q1 2026), $214.3 million (Q4 2025), and $214.4 million (Q3 2025), per Business Quant data.